Empery Asset Management's 7.57% Stake in Outlook Therapeutics

SEC Filing SCHEDULE 13G (0000902664-25-003290)

Empery Asset Management, LP, along with Ryan M. Lane and Martin D. Hoe, collectively referred to as the Reporting Persons, have filed a Schedule 13G indicating a 7.57% beneficial ownership in the common stock of Outlook Therapeutics, Inc. The filing, made under Rule 13d-1(b), reports ownership of 3,195,641 shares as of May 23, 2025. The Reporting Persons disclaim beneficial ownership of the shares except to the extent of their pecuniary interest. The filing is significant as it reflects a substantial stake in the company, which could influence corporate decisions and investor perceptions.